Find Narazaciclib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1357470-29-1, On123300, On-123300, Narazaciclib, Qj8ro3296g, Chembl3115681
Molecular Formula
C24H27N7O
Molecular Weight
429.5  g/mol
InChI Key
VADOZMZXXRBXNY-UHFFFAOYSA-N
FDA UNII
QJ8RO3296G

Narazaciclib
Narazaciclib is an orally bioavailable inhibitor of NUAK family SNF1-like kinase 1 (AMPK-related protein kinase 5; ARK5), and the cyclin-dependent kinases 4 (CDK4) and 6 (CDK6), with potential antineoplastic activity. Upon oral administration,narazaciclib specifically binds to and inhibits ARK5, which interferes with the activation of ARK5-mediated signal transduction pathways and reduces cell proliferation in cancer cells that overexpress ARK5. In addition, ON 123300 inhibits CDK4 and 6 and prevents the phosphorylation of retinoblastoma (Rb) protein in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, which causes G1 phase cell cycle arrest, suppresses DNA synthesis and inhibits cancer cell growth. ARK5, a member of the AMP-activated protein kinase (AMPK) family, is associated with tumor growth and invasion. Overexpression of CDK4/6, which is seen in certain types of cancer, causes cell cycle deregulation.
1 2D Structure

Narazaciclib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
8-cyclopentyl-2-[4-(4-methylpiperazin-1-yl)anilino]-7-oxopyrido[2,3-d]pyrimidine-6-carbonitrile
2.1.2 InChI
InChI=1S/C24H27N7O/c1-29-10-12-30(13-11-29)20-8-6-19(7-9-20)27-24-26-16-18-14-17(15-25)23(32)31(22(18)28-24)21-4-2-3-5-21/h6-9,14,16,21H,2-5,10-13H2,1H3,(H,26,27,28)
2.1.3 InChI Key
VADOZMZXXRBXNY-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C4C=C(C(=O)N(C4=N3)C5CCCC5)C#N
2.2 Other Identifiers
2.2.1 UNII
QJ8RO3296G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. On123300

2.3.2 Depositor-Supplied Synonyms

1. 1357470-29-1

2. On123300

3. On-123300

4. Narazaciclib

5. Qj8ro3296g

6. Chembl3115681

7. Pyrido(2,3-d)pyrimidine-6-carbonitrile, 8-cyclopentyl-7,8-dihydro-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxo-

8. 8-cyclopentyl-2-[4-(4-methylpiperazin-1-yl)anilino]-7-oxopyrido[2,3-d]pyrimidine-6-carbonitrile

9. Unii-qj8ro3296g

10. On 123300

11. Narazaciclib [inn]

12. Schembl10050883

13. Gtpl11879

14. Bcp19186

15. Ex-a1111

16. Bdbm50447512

17. Mfcd28411414

18. Nsc802100

19. S8161

20. Akos030526450

21. Zinc103269269

22. Ccg-268995

23. Cs-5570

24. Nsc-802100

25. Sb16989

26. Compound 7x [pmid: 24417566]

27. Ac-35541

28. As-35286

29. Hy-12624

30. Db-100781

31. A857300

32. Q27287291

33. 8-cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile;on 123300

34. 8-cyclopentyl-2-[4-(4-methyl-piperazine-1-yl)-phenylamino]-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile

2.4 Create Date
2012-03-02
3 Chemical and Physical Properties
Molecular Weight 429.5 g/mol
Molecular Formula C24H27N7O
XLogP33.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass429.22770851 g/mol
Monoisotopic Mass429.22770851 g/mol
Topological Polar Surface Area88.4 Ų
Heavy Atom Count32
Formal Charge0
Complexity754
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Looking for 1357470-29-1 / Narazaciclib API manufacturers, exporters & distributors?

Narazaciclib manufacturers, exporters & distributors 1

45

PharmaCompass offers a list of Narazaciclib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Narazaciclib manufacturer or Narazaciclib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Narazaciclib manufacturer or Narazaciclib supplier.

PharmaCompass also assists you with knowing the Narazaciclib API Price utilized in the formulation of products. Narazaciclib API Price is not always fixed or binding as the Narazaciclib Price is obtained through a variety of data sources. The Narazaciclib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Narazaciclib

Synonyms

1357470-29-1, On123300, On-123300, Qj8ro3296g, Chembl3115681, Pyrido(2,3-d)pyrimidine-6-carbonitrile, 8-cyclopentyl-7,8-dihydro-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxo-

Cas Number

1357470-29-1

Unique Ingredient Identifier (UNII)

QJ8RO3296G

About Narazaciclib

Narazaciclib is an orally bioavailable inhibitor of NUAK family SNF1-like kinase 1 (AMPK-related protein kinase 5; ARK5), and the cyclin-dependent kinases 4 (CDK4) and 6 (CDK6), with potential antineoplastic activity. Upon oral administration,narazaciclib specifically binds to and inhibits ARK5, which interferes with the activation of ARK5-mediated signal transduction pathways and reduces cell proliferation in cancer cells that overexpress ARK5. In addition, ON 123300 inhibits CDK4 and 6 and prevents the phosphorylation of retinoblastoma (Rb) protein in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, which causes G1 phase cell cycle arrest, suppresses DNA synthesis and inhibits cancer cell growth. ARK5, a member of the AMP-activated protein kinase (AMPK) family, is associated with tumor growth and invasion. Overexpression of CDK4/6, which is seen in certain types of cancer, causes cell cycle deregulation.

Narazaciclib Manufacturers

A Narazaciclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Narazaciclib, including repackagers and relabelers. The FDA regulates Narazaciclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Narazaciclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Narazaciclib Suppliers

A Narazaciclib supplier is an individual or a company that provides Narazaciclib active pharmaceutical ingredient (API) or Narazaciclib finished formulations upon request. The Narazaciclib suppliers may include Narazaciclib API manufacturers, exporters, distributors and traders.

Narazaciclib GMP

Narazaciclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Narazaciclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Narazaciclib GMP manufacturer or Narazaciclib GMP API supplier for your needs.

Narazaciclib CoA

A Narazaciclib CoA (Certificate of Analysis) is a formal document that attests to Narazaciclib's compliance with Narazaciclib specifications and serves as a tool for batch-level quality control.

Narazaciclib CoA mostly includes findings from lab analyses of a specific batch. For each Narazaciclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Narazaciclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Narazaciclib EP), Narazaciclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Narazaciclib USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty